Provided by Tiger Trade Technology Pte. Ltd.

GlucoTrack, Inc.

3.68
-0.5700-13.41%
Post-market: 3.760.0800+2.17%16:27 EDT
Volume:75.91K
Turnover:298.67K
Market Cap:2.60M
PE:-0.03
High:4.27
Open:4.08
Low:3.68
Close:4.25
52wk High:212.10
52wk Low:3.68
Shares:705.25K
Float Shares:701.36K
Volume Ratio:0.73
T/O Rate:10.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-112.7747
EPS(LYR):-468.2383
ROE:-620.63%
ROA:-164.45%
PB:-1.49
PE(LYR):-0.01

Loading ...

YSX Tech Stock Soars 14% After Hours: Here's Why

Benzinga Earnings
·
Jul 15

Glucotrack (GCTK) Stock Is Trending Overnight — Here’s Why it Spiked Over 69% in After-Hours Session

Benzinga_recent_news
·
Jul 15

Glucotrack Names Erik Emerson CEO, Paul Goode CTO in Lōkahi Deal

Reuters
·
Jul 15

Press Release: Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-controlled Public Platform

Dow Jones
·
Jul 15

GlucoTrack announces USPTO notice of allowance for patent application

TIPRANKS
·
Jul 08

Glucotrack Says USPTO Allows Patent Claims for Implantable Continuous Blood Glucose Monitoring Platform

Reuters
·
Jul 08

Glucotrack Announces Uspto Notice of Allowance for Patent Application Covering Its Implantable Cbgm Platform

THOMSON REUTERS
·
Jul 08

GlucoTrack announces 2026 annual shareholder meeting

Reuters
·
Jun 18

GlucoTrack IDE submission enters FDA review for implantable blood glucose monitor

Reuters
·
May 26

Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions

GlobeNewswire
·
May 26

GlucoTrack faces Nasdaq delisting over minimum bid price deficiency

Reuters
·
May 16

GlucoTrack's Q1 net loss narrows

Reuters
·
May 15

GlucoTrack Q1 EPS $(2.65) Up From $(40.20) YoY

Benzinga Earnings
·
May 15

GlucoTrack Q1 FY26 net loss narrows to USD 4.33 million

Reuters
·
May 15

GlucoTrack Q1 Net Income USD 4.334 Million

THOMSON REUTERS
·
May 15

GlucoTrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

THOMSON REUTERS
·
May 15

Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

GlobeNewswire
·
May 15

GlucoTrack Inc - Submits Ide Application to FDA for US Clinical Study of Implantable Cbgm Technology - SEC Filing

THOMSON REUTERS
·
May 08

Glucotrack submits IDE application to FDA for US implantable glucose monitor study

Reuters
·
May 08

GlucoTrack Announces Ide Submission for U.S. Clinical Study of Its Novel Implantable Continuous Blood Glucose Monitoring Technology

THOMSON REUTERS
·
May 08